Brief: China Grand Pharmaceutical And Healthcare Proposed To Stake In Cangzhou Huachen Biotech
18/10/2021 16:35
Oct 18 (Reuters) - China Grand Pharmaceutical and Healthcare
Holdings Ltd 0512.HK :
* PROPOSED TO ACQUIRE 80% EQUITY OF CANGZHOU HUACHEN BIOTECH
FOR
RMB107.2 MILLION
Further company coverage: 0512.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement